3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
8
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Anus Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Smoking
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Myocarditis
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoproliferative Disorders
1
Interventions
pembrolizumab
4
Proton Therapy
3
toripalimab
1
spartalizumab
1
patritumab deruxtecan
1
osimertinib
1
mirdametinib
1
leronlimab
1
amivantamab
1
Valganciclovir
1
Radiotherapy
1
Paclitaxel
1
Lacteol
1
Interleukin-2
1
Docetaxel
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
BGB-283
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
Tomography, X-Ray Computed
×
1 year
×
Clear all
No trials found.